Simultaneous assessment of membrane-stabilizing and β-adrenoceptor blocking activity of drugs with the rat isolated left atria

Amerini, 1986, In vitro evaluation of the beta-blocking and electrophysiological properties of mepindolol, Arch Int Pharmacodynam Ther, 282, 276 Arunlakshana, 1959, Some quantitative uses of drug antagonists, Br J Pharmacol, 14, 48 Barrett, 1968, The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias, Br J Pharmacol, 34, 53, 10.1111/j.1476-5381.1968.tb07949.x Bradley, 1984, Effects of the (±)-, (+)- and (−)-forms of propranolol, timolol and metoprolol on noradrenergic transmission in the rat isolated right ventricle, Arch Int Pharmacodyanam Ther, 270, 261 Doggrell, 1985, Comparison of the effects of labetalol and SCH 19927 R1R isomer of labetalol, on the rat isolated right ventricle and aorta, J Autonom Pharmacol, 5, 279, 10.1111/j.1474-8673.1985.tb00551.x Doggrell, 1986, On the assessment of the β-adrenoceptor blocking activity of propranolol using the rat isolated right ventricle, J Pharmacol Meth, 15, 119, 10.1016/0160-5402(86)90061-6 Doggrell, 1981, The use of the rat right ventricle in studies on noradrenergic transmission, J Autonom Pharmacol, 1, 189, 10.1111/j.1474-8673.1981.tb00446.x Fitzgerald, 1984, β-Adrenoceptor antagonists, Volume 3, 249 Harting, 1986, Pharmacodynamic profile of the selective β1-adrenoceptor antagonist bisoprolol, Drug Res, 36, 200 Hellenbrecht, 1973, Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the nonspecific membrane affinity of nine β-adrenergic blocking agents, Naunyn-Schmiedebergs Arch Pharmacol, 277, 211, 10.1007/BF00501161 Ishida, 1980, Local anaesthetic activity of β-adrenergic blocking drugs in the crayfish giant axon, with reference to calcium ion, Jpn J Pharmacol, 30, 607, 10.1254/jjp.30.607 Van Rossum, 1983, Cumulative dose-response curves II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters, Arch Int Pharmacodynan Ther, 143, 299